Bio-Rad’s Sales Dip: Optimism for 2024?
Bio-Rad Laboratories reports Q4 2023 net sales decline amidst biotech challenges. Full-year 2023 net sales also show a decrease. However, ...
- Latest
- Trending
Bio-Rad Laboratories reports Q4 2023 net sales decline amidst biotech challenges. Full-year 2023 net sales also show a decrease. However, ...
President Yoon Suk Yeol expands science and technology scholarships for graduate students in Korea, aiming to boost competitiveness in these ...
The University of Pennsylvania is introducing an undergraduate major in artificial intelligence, aiming to equip students with a comprehensive understanding ...
Microsoft's €3.2bn investment in Germany aims to boost the country's AI infrastructure, train 1.2 million people in digital skills, and ...
The Dow Jones Industrial Average surges 0.3%, led by strong performances from Walgreens Boots and Dow shares. Analysts predict continued ...
Pacira BioSciences introduces EXPAREL, an opioid-sparing pain management solution. Promising Phase 3 study outcomes show significant pain reduction and decreased ...
Lexaria Bioscience announces a $3.6 million offering and private placement to enhance operational capabilities and drive innovation in the pharmaceutical ...
Leidos secures $143M DIA contract to enhance open source intelligence with AI and ML, reinforcing national defense mechanisms. Positive news ...
Hawaii state lawmakers are leading efforts to regulate advanced AI technology, aiming to strike a balance between innovation and public ...
The ZLUDA project could disrupt the GPU-based computing market by allowing CUDA applications to run on AMD GPUs, boosting AMD's ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.